Circadian Rhythm and Relapse Data from 103 AUD Patients Using Actigraphy

126 treatment-seeking individuals with Alcohol Use Disorder (AUD) wore Philips Respironics Actiwatches for up to 7 days inpatient and 4 weeks outpatient to study circadian rhythm dysregulation. The final cohort included 103 participants for outpatient analysis, with 25.2% relapsing during the study period. Results indicate a moderate decrease in hourly intradaily variability and a later wake time of about 1 hour following relapse.

Use Cases

• Predicting relapse risk based on circadian rhythm metrics like interdaily stability and intradaily variability
• Analyzing the effect of discharge from inpatient treatment on activity patterns measured by actigraphy
• Modeling the relationship between daily most active 10 hours (M10) and least active 5 hours (L5) with alcohol consumption

Strengths

• Includes actigraphy data from 126 participants with AUD, a specific clinical population
• Provides longitudinal data with both inpatient (up to 7 days) and outpatient (4 weeks) monitoring periods
• Reports specific circadian rhythm statistics like interdaily stability (IS), intradaily variability (IV), M10, L5, and relative amplitude (RA)

Limitations

• Column-level documentation is absent; field semantics must be inferred after download
• Row count is unknown, which may limit suitability assessment
• Data may reflect bias inherent to the specific inpatient treatment program and participant cohort

Provenance

Source

figshare

Collection Method

Actigraphy data collected from participants wearing Philips Respironics Actiwatches during inpatient treatment and a subsequent outpatient period.

Freshness

Last updated 2026-05-01 05:27:49; freshness should be verified